価格表

在庫・価格 : 2024年06月10日 01時16分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Myostatin Propeptide, Mouse, Recombinant <GDF-8 Propeptide>
データシート
1539-PG-025 RSDアールアンドディー システムス
R&D Systems, Inc.
25 μg ¥105,000
(未発注)
追加

在庫・価格 : 2024年06月10日 01時16分 現在

Myostatin Propeptide, Mouse, Recombinant <GDF-8 Propeptide>

  • 商品コード:1539-PG-025
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥105,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Ohsawa Y et al. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition. J. Clin. Invest. 2006 Nov;116(11):2924-34
Ohsawa Y et al
2006/01/01
Application: Immunoprecipitation Control, Sample Type: Homogenized Tissue,Serum PubMed
2 Sengle G et al. Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J. Biol. Chem. 2008 May;283(20):13874-88
Sengle G et al
2008/01/01
Species: Human, Application: Biacore binding study, complex formation, recombinant Fibrillin PubMed
3 Sengle G et al. A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7. J. Mol. Biol. 2008 Sep;381(4):1025-39
Sengle G et al
2008/01/01
Species: Human, Application: Biacore binding study, ELISA development, recombinant ActRIA, recombinant ActRIIA, recombinant ActRIIB, recombinant BMPRIA, recombinant BMPRIB, recombinant BMPRII PubMed
4 Sengle G et al. Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability. J. Biol. Chem. 2011 Feb;286(7):5087-99
Sengle G et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
5 Lee SB et al. Maltose binding protein-fusion enhances the bioactivity of truncated forms of pig myostatin propeptide produced in E. coli. PLoS ONE 2017;12(4):e0174956
Lee SB et al
2017/01/01
Application: Bioassay,Enzyme Activity, Sample Type: Whole Cells,recombinant protein PubMed
  • No.: 1
  • 文献情報:
    Ohsawa Y et al. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition. J. Clin. Invest. 2006 Nov;116(11):2924-34
    Ohsawa Y et al
    2006/01/01
  • 備考:
    Application: Immunoprecipitation Control, Sample Type: Homogenized Tissue,Serum
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Sengle G et al. Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J. Biol. Chem. 2008 May;283(20):13874-88
    Sengle G et al
    2008/01/01
  • 備考:
    Species: Human, Application: Biacore binding study, complex formation, recombinant Fibrillin
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Sengle G et al. A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7. J. Mol. Biol. 2008 Sep;381(4):1025-39
    Sengle G et al
    2008/01/01
  • 備考:
    Species: Human, Application: Biacore binding study, ELISA development, recombinant ActRIA, recombinant ActRIIA, recombinant ActRIIB, recombinant BMPRIA, recombinant BMPRIB, recombinant BMPRII
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Sengle G et al. Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability. J. Biol. Chem. 2011 Feb;286(7):5087-99
    Sengle G et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Lee SB et al. Maltose binding protein-fusion enhances the bioactivity of truncated forms of pig myostatin propeptide produced in E. coli. PLoS ONE 2017;12(4):e0174956
    Lee SB et al
    2017/01/01
  • 備考:
    Application: Bioassay,Enzyme Activity, Sample Type: Whole Cells,recombinant protein
  • 参照:
    PubMed